The FTC recently launched an investigation into PBMs regarding their role in increasing prescription drug prices. In this episode, we talk with Catherine Hall, RN, Director of Prescription Drug Management for SentryHealth about the inquiry and how benefits advisors can protect their clients from bad PBM practices.
